Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Bjpsych Open
|
September 4, 2023
Clozapine and Sweet's syndrome: case report
Apphia Bunting, Daniel Silman, Minesh Karia, et al.
Vaccine
|
August 7, 2017
Vaccines against Ebola virus
Navin Venkatraman, Daniel Silman, Pedro M Folegatti, et al.
Bjpsych Open
|
December 22, 2025
Longitudinal validation of the Maudsley 3-item visual analogue scale (M3VAS): a new, brief, patient-reported outcome measure of depression
Daniel Silman, Maria Elena Middag, Anthony J Cleare, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 20, 2025
A randomized, double-blind, placebo-controlled, Phase 1 study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an immediate-release oral ketamine capsule in healthy volunteers
Mutahira Qureshi, Daniel Silman, Romayne Gadelrab, et al.
Trials
|
November 6, 2025
A randomised controlled trial to evaluate the clinical and cost-effectiveness of Stimulant compared with Non-stimulant medication for adults with Attention-deficit/hyperactivity disorder and a history of Psychosis or biPolar disordER: SNAPPER
Shrushma Loi, Paras Joshee, Ryan Ottridge, et al.
Science Translational Medicine
|
September 28, 2018
Prime and target immunization protects against liver-stage malaria in mice
Anita Gola, Daniel Silman, Adam A Walters, et al.
Wellcome Open Research
|
April 13, 2026
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults
Daniel Silman, Amy Flaxman, Mehreen Datoo, et al.
The Lancet. Infectious Diseases
|
April 24, 2020
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Pedro M Folegatti, Mustapha Bittaye, Amy Flaxman, et al.
The Lancet. Microbe
|
January 13, 2025
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study
Navin Venkatraman, Daniel Silman, Duncan Bellamy, et al.
Journal of Affective Disorders
|
January 31, 2026
Personal recovery as outcome measure in mental health research: A meta-analysis on the sensitivity to change properties of the Recovery Assessment Scale
T A D Pelgrim, K Kleine Schaars, R Moldovan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Bjpsych Open
|
September 4, 2023
Clozapine and Sweet's syndrome: case report
Apphia Bunting, Daniel Silman, Minesh Karia, et al.
Vaccine
|
August 7, 2017
Vaccines against Ebola virus
Navin Venkatraman, Daniel Silman, Pedro M Folegatti, et al.
Bjpsych Open
|
December 22, 2025
Longitudinal validation of the Maudsley 3-item visual analogue scale (M3VAS): a new, brief, patient-reported outcome measure of depression
Daniel Silman, Maria Elena Middag, Anthony J Cleare, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 20, 2025
A randomized, double-blind, placebo-controlled, Phase 1 study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an immediate-release oral ketamine capsule in healthy volunteers
Mutahira Qureshi, Daniel Silman, Romayne Gadelrab, et al.
Trials
|
November 6, 2025
A randomised controlled trial to evaluate the clinical and cost-effectiveness of Stimulant compared with Non-stimulant medication for adults with Attention-deficit/hyperactivity disorder and a history of Psychosis or biPolar disordER: SNAPPER
Shrushma Loi, Paras Joshee, Ryan Ottridge, et al.
Science Translational Medicine
|
September 28, 2018
Prime and target immunization protects against liver-stage malaria in mice
Anita Gola, Daniel Silman, Adam A Walters, et al.
Wellcome Open Research
|
April 13, 2026
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults
Daniel Silman, Amy Flaxman, Mehreen Datoo, et al.
The Lancet. Infectious Diseases
|
April 24, 2020
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Pedro M Folegatti, Mustapha Bittaye, Amy Flaxman, et al.
The Lancet. Microbe
|
January 13, 2025
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study
Navin Venkatraman, Daniel Silman, Duncan Bellamy, et al.
Journal of Affective Disorders
|
January 31, 2026
Personal recovery as outcome measure in mental health research: A meta-analysis on the sensitivity to change properties of the Recovery Assessment Scale
T A D Pelgrim, K Kleine Schaars, R Moldovan, et al.
Page
of 2